International Public Lecture at Australian National University – featuring Professor David Nutt (UK), Head of Neuropsychopharmacology at Imperial College London · Mind Medicine Australia
Mind Medicine Australia logo
Donate

International Public Lecture at Australian National University – featuring Professor David Nutt (UK), Head of Neuropsychopharmacology at Imperial College London

With Prof David Nutt (UK), Prof Paul Fitzgerald, Tania de Jong AM and Peter Hunt AM

Date: Tue 22 November 2022 @ 5:30pm
Location: Australian National University: Cultural Centre Kambri (ANU Building 153) Upper Level, Cultural Centre, T2 University Avenue Acton, ACT 2601

Mind Medicine Australia is delighted to present an International Public Lecture featuring Professor David Nutt (UK), Head of Neuropsychopharmacology at Imperial College London (live in person).

This special event will feature a keynote by Professor Nutt titled ‘Psychedelic-Assisted Therapies: The History, Neuroscience and Myths’ followed by a Q & A panel.

International Keynote: ‘Psychedelic-Assisted Therapies: History, Neuroscience and Myths.’

Professor Nutt will explain:

Following the presentation, there will be a Q & A panel with Professor David Nutt (UK), clinicans in the space and lived clinicians and those with lived experience.

This is an unmissable opportunity to engage in a discussion about psychedelic-assisted therapies and treatments for chronic mental health conditions, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Don’t miss out – Get your tickets early!

Date: Tuesday 22 November

Time: 5:30pm until 7:00pm

Location: Cultural Centre Kambri (ANU Building 153) Upper Level, Cultural Centre, T2 University Avenue Acton, ACT 2601

 

You will be supporting Mind Medicine Australia’s mission to provide accessible and affordable psychedelic-assisted therapies to treat a range of mental illnesses in medically controlled environments. Mind Medicine Australia exists to help alleviate the suffering caused by our accelerating mental illness epidemic in Australia, through expanding the treatment options available to medical practitioners and their patients.

OUR PARTNERS:

 

 

The Presenters

Prof David Nutt (UK)

BA, MB BChir, MRCP, MA, DM, MRC Psych, FRCPsych, FMedSci, FRCP, FSB

Renowned researcher, policy advisor and author, Professor David Nutt, is currently Head of Neuropsychopharmacology at Imperial College London and the Chair of Drug Science.

Under the leadership of Professor Nutt, the Psychedelic Research Group at Imperial College is one of the world’s foremost psychedelic research laboratories, publishing landmark research on psychedelic therapies and neuroimaging studies of the psychedelic state.

Professor Nutt has also held many leadership positions in both UK and European academic, scientific and clinical organisations, including presidencies of: the European Brain Council, the British Neuroscience Association, the British Association of Psychopharmacology, the European College of Neuropsychopharmacology.

He was previously Chair of the UK Advisory Council on the Misuse of Drugs.

Prof Paul Fitzgerald

MBBS, MPM, Ph.D, FRANZCP

Paul Fitzgerald is Professor of Psychiatry at Monash University and Director of the Epworth Centre for Innovation in Mental Health based at Epworth Camberwell. He is a qualified psychiatrist, has a Masters of Psychological Medicine and research PhD. His main clinical and academic interest is in the development, evaluation and clinical translation of new therapies for mental health conditions. His research program has been mainly focussed on various forms of brain stimulation including transcranial magnetic stimulation (TMS), transcranial alternating current stimulation, magnetic seizure therapy and deep brain stimulation.

He has conducted over twenty clinical trials in depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease along with numerous experimental studies. He has established multiple clinical TMS services, is a founder and board member of TMS Clinics Australia, and established Australia’s first TMS clinical training program. He has had continual NHMRC grant support for almost 20 years.

Tania de Jong AM

LL.B (Hons), GradDipMus

Co-founder Mind Medicine Australia, Founder Creative Universe, Creativity Australia, The Song Room & Creative Innovation Global

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×